Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial (Q33435967)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial |
scientific article |
Statements
1 reference
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial (English)
1 reference
1 reference
Padmanee Sharma
1 reference
Margaret K Callahan
1 reference
Petri Bono
1 reference
Joseph Kim
1 reference
Pavlina Spiliopoulou
1 reference
Emiliano Calvo
1 reference
Rathi N Pillai
1 reference
Patrick A Ott
1 reference
Michael Morse
1 reference
Dung T Le
1 reference
Dirk Jaeger
1 reference
Emily Chan
1 reference
Chris Harbison
1 reference
Chen-Sheng Lin
1 reference
Marina Tschaika
1 reference
Alex Azrilevich
1 reference
Jonathan E Rosenberg
1 reference
9 October 2016
1 reference
1 reference
1590-1598
1 reference
Identifiers
1 reference
1 reference
1 reference